13
Sep
2021
Office Leasing Rates Remain Stable Amid Delta Variant Emergence
Posted On September 13, 2021  By Irina Lupa  And has 1 Comment

The emergence of the COVID-19 Delta variant has played an important part in delaying some planned returns to the office. However, many businesses have been well equipped to adapt to the continually shifting economic environment. While some companies are pushing reopening dates later in the fall […]

Read More

27
Jul
2021
Biomed, Life Science Clusters Capture Lab-Focused Investor Interest
Posted On July 27, 2021  By Ioana Ginsac  And has 2 Comments

Rising consumer spending, greater mobility and improved vaccination rates are contributing significantly to bringing back commercial activity to markets that have been impacted by challenges associated with social distancing, limited travel and density. While long-term space planning remains somewhat fluid, flexibility on concessions rather than on […]

Read More

24
Mar
2021
Life Sciences Innovators Need Inspired Workplaces
Posted On March 24, 2021  By Ken Wardingley and Tina Kocoras  And has 1 Comment

Life sciences firms are under intense pressure right now to research and produce viable COVID-19 vaccines, and their workplaces and labs need to support their vital work. While many current pharmaceutical office trends will continue, new priorities are emerging that include accessible outdoor space, increased security […]

Read More

08
Oct
2020
The Three Biggest CRE Opportunities Post-COVID 19
Posted On October 8, 2020  By Marie Ruff  And has No Comment

The pandemic has directly impacted commercial real estate – with shutdowns, supply chain disruption, changing consumer habits, and more – and accelerated some existing trends like increasing reliance on e-commerce and widespread adoption of working from home. Three leading industry experts at CRE.Converge Virtual 2020 shared […]

Read More

22
Sep
2020
How Life Sciences Labs are Boosting Productivity to Meet Growing Demand
Posted On September 22, 2020  By Roger Humphrey  And has No Comment

The life sciences industry has been a bright spot in the U.S. economy, with private investors putting more than $16 billion to work in the first half of 2020. That is in addition to a steady stream of government funding, with the National Institutes of Health […]

Read More